Inventor

GILLARD JOHN W

CA35 patents

⚠️ This page may combine multiple inventors who share the name “GILLARD JOHN W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

GILLARD JOHN W

MERCK FROSST CANADA INC

(hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis

Indole-2-alkanoic acids compositions of and anti allergic use thereof

3-hetero-substituted-n-benzyl-indoles and prevention of leucotriene synthesis therewith

(Polycyclic-arylmethoxy) indoles as inhibitors of leukotriene biosynthesis

(Azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis

(Bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis

3-hetero-substituted-N-benzyl-indoles and medical methods of use therefor

(quinolin-2-ylmethoxy)tetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes

Heteroarylnaphthalene hydroxy acids as inhibitors of leukotriene biosynthesis

(quinolin-2-ylmethoxy)heterotetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes

Tetrahydrocarbazole 1-alkanoic acids and pharmaecutical compositions

Tetrahydrocarbazole esters, pharmaceutical compositions and use

Pyranylphenyl hydroxyalkylnaphthoic acids as inhibitors of leukotriene biosynthesis

Heteroarylnaphthalene lactones as inhibitors of leukotriene biosynthesis

Cyclohept(B)indolealkanoic acids, pharmaceutical compositions and use

Cyclohept[b]indoleakanoic acids, pharmaceutical compositions and use

Substituted phenylalkenoic acids and esters

Substituted phenylalkenoic acids and esters

Process for preparing substituted phenylalkenoic acids

Pyranylphenyl naphthalene lactones as inhibitors of leukotriene biosynthesis

Leukotriene antagonists

Cyclohept[b]indolealkanoic acids, pharmaceutical compositions and use

AEGERA THERAPEUTICS INC

IAP BIR domain binding compounds

Imidazo [2,1-b]-1,3,4-thiadiazole sulfonamides

Neuroprotective and anti-proliferative compounds

Imidazo[2,1-b ]-1,3,4-thiadiazole sulfonamides

Imidazo[2,1-b]-1,3,4-thiadiazole sulfonamides

Imidazo[2, 1-b]-1,3,4-thiadiazole sulfonamides

MERCK & CO INC

Tetrahydrocarbazole 1-alkanoic acids, pharmaceutical compositions and use

5-lipoxygenase activating protein

PHARMASCIENCE INC

IAP BIR domain binding compounds

IAP BIR domain binding compounds

MERCK FROSST CANADA

Cyclohept[b]indolealkanoic acids, pharmaceutical compositions and use

IAF BIOCHEM INT

Low molecular weight bicyclic thrombin inhibitors

DIANOVIX INC

Method for differentiating between multiple sclerosis subtypes